AAAAAA
Results: 1-25/51
Authors:
SAHARAY M
SHIELDS DA
GEORGIANNOS SN
PORTER JB
SCURR JH
SMITH PDC
Citation: M. Saharay et al., ENDOTHELIAL ACTIVATION IN PATIENTS WITH CHRONIC DISEASE, European journal of vascular and endovascular surgery, 15(4), 1998, pp. 342-349
Authors:
PORTER JB
ALBERTI D
HASSAN I
RACINE A
DAVIS B
VOI V
PIGA A
Citation: Jb. Porter et al., PHASE-I, SINGLE-DOSE TRIAL ON DEPOT DESFERRIOXAMINE (CGH 749B) IN TRANSFUSION-DEPENDENT BETA-THALASSEMIC PATIENTS, British Journal of Haematology, 102(1), 1998, pp. 280-280
Authors:
MCDONALD SJ
LAWRIE AS
PURDY G
MACKIE IJ
PORTER JB
MACHIN SJ
Citation: Sj. Mcdonald et al., ENDOTHELIAL DAMAGE IN SICKLE-CELL DISEASE, British Journal of Haematology, 102(1), 1998, pp. 357-357
Authors:
MUNDEE Y
BIGELOW N
DAVIS BH
PORTER JB
Citation: Y. Mundee et al., EVALUATION OF A NEW FLOW CYTOMETRIC METHOD FOR MEASUREMENT OF FETAL HEMOGLOBIN CONTAINING RETICULOCYTES (F-RETICS), British Journal of Haematology, 101, 1998, pp. 126-126
Authors:
WIENER E
ALLEN D
PORTER RJ
WICKRAMASINGHE SN
PORTER JB
CHINPRASERTSUK S
SIRIPANYAPHINYO U
PATTANAPANYSAT K
FUCHAROEN S
WANACHIWANAWIN W
Citation: E. Wiener et al., UP-REGULATION OF FC-GAMMA-RI AND ITS ROLE IN RED-CELL DESTRUCTION IN THALASSEMIA, British Journal of Haematology, 101, 1998, pp. 127-127
Authors:
CURNOW A
MCILROY BW
POSTLEHACON MJ
PORTER JB
MACROBERT AJ
BOWN SG
Citation: A. Curnow et al., ENHANCEMENT OF 5-AMINOLEVULINIC ACID-INDUCED PHOTODYNAMIC THERAPY IN NORMAL RAT COLON USING HYDROXYPYRIDINONE IRON-CHELATING AGENTS, British Journal of Cancer, 78(10), 1998, pp. 1278-1282
Authors:
MOLLAPOUR E
PORTER JB
KACZMARSKI R
LINCH DC
ROBERTS PJ
Citation: E. Mollapour et al., RAISED NEUTROPHIL PHOSPHOLIPASE A(2) ACTIVITY AND DEFECTIVE PRIMING OF NADPH OXIDASE AND PHOSPHOLIPASE A(2) IN SICKLE-CELL DISEASE, Blood, 91(9), 1998, pp. 3423-3429
Authors:
CHANG SC
MACROBERT AJ
PORTER JB
BOWN SG
Citation: Sc. Chang et al., THE EFFICACY OF AN IRON CHELATOR (CP94) IN INCREASING CELLULAR PROTOPORPHYRIN-IX FOLLOWING INTRAVESICAL 5-AMINOLEVULINIC ACID ADMINISTRATION - AN IN-VIVO STUDY, Journal of photochemistry and photobiology.B, Biology, 38(2-3), 1997, pp. 114-122
Authors:
RATIP S
PETROU M
OLD JM
WONKE B
PORTER JB
MONDELL B
Citation: S. Ratip et al., RELATIONSHIP BETWEEN THE SEVERITY OF BETA-THALASSEMIA SYNDROMES AND THE NUMBER OF ALLEVIATING MUTATIONS, European journal of haematology, 58(1), 1997, pp. 14-21
Authors:
SAHARAY M
SHIELDS DA
PORTER JB
SCURR JH
SMITH PDC
Citation: M. Saharay et al., LEUKOCYTE ACTIVITY IN THE MICROCIRCULATION OF THE LEG IN PATIENTS WITH CHRONIC VENOUS DISEASE, Journal of vascular surgery, 26(2), 1997, pp. 265-273
Authors:
MCDONALD SJ
LAWRIE AS
PURDY G
MACKIE IJ
PORTER JB
MACHIN SJ
Citation: Sj. Mcdonald et al., HEMOSTATIC REGULATION IN THE HEMOGLOBINOPATHIES, Thrombosis and haemostasis, 1997, pp. 1876-1876
Authors:
COOPER CE
PORTER JB
Citation: Ce. Cooper et Jb. Porter, RIBONUCLEOTIDE REDUCTASE, LIPOXYGENASE AND THE INTRACELLULAR LOW-MOLECULAR-WEIGHT IRON POOL, Biochemical Society transactions, 25(1), 1997, pp. 75-80
Authors:
SAHARAY M
SHIELDS DA
PORTER JB
SCURR JH
SMITH PDC
Citation: M. Saharay et al., LEUKOCYTE ACTIVITY IN VOLUNTEERS IN RESPONSE TO EXPERIMENTAL VENOUS HYPERTENSION, Phlebology, 12(4), 1997, pp. 122-126
Authors:
SHIELDS DA
ANDAZ SK
PORTER JB
SCURR JH
SMITH PDC
Citation: Da. Shields et al., SOLUBLE MARKERS OF LEUKOCYTE ADHESION IN PATIENTS WITH VENOUS DISEASE, Phlebology, 12(3), 1997, pp. 82-85
Authors:
PORTER JB
Citation: Jb. Porter, A RISK-BENEFIT ASSESSMENT OF IRON-CHELATION THERAPY, Drug safety, 17(6), 1997, pp. 407-421
Authors:
BRADLEY SJ
GOSRIWITANA I
SRICHAIRATANAKOOL S
HIDER RC
PORTER JB
Citation: Sj. Bradley et al., NON-TRANSFERRIN-BOUND IRON-INDUCED BY MYELOABLATIVE CHEMOTHERAPY, British Journal of Haematology, 99(2), 1997, pp. 337-343
Authors:
PIGA A
ALBERTI D
HASSAN I
RACINE A
VOI V
ALEXANDER E
ADAMS C
PORTER JB
Citation: A. Piga et al., EFFICACY OF A NEW FORMULATION OF DESFERRIOXAMINE (CGH 749B) GIVEN AS SUBCUTANEOUS BOLUS INJECTIONS IN TRANSFUSION-DEPENDENT BETA-THALASSEMIC PATIENTS, Blood, 90(10), 1997, pp. 32-32
Authors:
MUNDEE Y
ZACHARY I
MARTIN J
PORTER JB
Citation: Y. Mundee et al., INCREASED LEVELS OF VASCULAR ENDOTHELIAL-DERIVED GROWTH-FACTOR AND NITRIC-OXIDE IN SICKLE-CELL DISEASE, Blood, 90(10), 1997, pp. 560-560
Authors:
PORTER JB
ALBERTI D
HASSAN I
HOWES C
STALLIBRASS L
RACINE A
ALEXANDER E
DAVIS B
VOL V
BROOKMAN L
PIGA A
Citation: Jb. Porter et al., SUBCUTANEOUS DEPOT DESFERRIOXAMINE (CGH 749B) - RELATIONSHIP OF PHARMACOKINETICS TO EFFICACY AND DRUG-METABOLISM, Blood, 90(10), 1997, pp. 1163-1163
Authors:
CHAVDA N
MACKIE IJ
PORTER JB
HARRISON P
PATTERSON K
MACHIN SJ
Citation: N. Chavda et al., RAPID FLOW CYTOMETRIC QUANTITATION OF RETICULATED PLATELETS IN WHOLE-BLOOD, Platelets, 7(4), 1996, pp. 189-194
Authors:
SHIELDS DA
SAHARAY M
TIMOTHYANTOINE C
PORTER JB
SCURR JH
SMITH PDC
Citation: Da. Shields et al., NEUTROPHIL CD11B EXPRESSION IN PATIENTS WITH VENOUS DISEASE, Phlebology, 11(2), 1996, pp. 55-59
Authors:
COOPER CE
LYNAGH GR
HOYES KP
HIDER RC
CAMMACK R
PORTER JB
Citation: Ce. Cooper et al., THE RELATIONSHIP OF INTRACELLULAR IRON CHELATION TO THE INHIBITION AND REGENERATION OF HUMAN RIBONUCLEOTIDE REDUCTASE, The Journal of biological chemistry, 271(34), 1996, pp. 20291-20299
Authors:
ABEYSINGHE RD
ROBERTS PJ
COOPER CE
MACLEAN KH
HIDER RC
PORTER JB
Citation: Rd. Abeysinghe et al., THE ENVIRONMENT OF THE LIPOXYGENASE IRON-BINDING SITE EXPLORED WITH NOVEL HYDROXYPYRIDINONE IRON CHELATORS, The Journal of biological chemistry, 271(14), 1996, pp. 7965-7972
Authors:
PORTER JB
ABEYSINGHE RD
MARSHALL L
HIDER RC
SINGH S
Citation: Jb. Porter et al., RELATIONSHIP OF KINETICS OF DESFERRIOXAMINE TO REMOVAL AND REAPPEARANCE OF NON-TRANSFERRIN-BOUND PLASMA IRON IN THALASSEMIA, British Journal of Haematology, 93, 1996, pp. 199-199
Authors:
BRADLEY SJ
OGUEJIOFOR NA
HIDER RC
PORTER JB
Citation: Sj. Bradley et al., NON-TRANSFERRIN BOUND IRON (NTBI) INDUCED BY CYTOTOXIC CHEMOTHERAPY, British Journal of Haematology, 93, 1996, pp. 325-325